6 Weeks Pregnant and Spotting When I Wipe

Spotting at 6 weeks pregnant? Get clear, expert guidance on understanding early pregnancy bleeding, knowing what’s normal, and when to seek medical advice.

Spotting at six weeks pregnant is common and, in most cases, does not signal a problem with the pregnancy. Roughly one in four pregnant women reports some vaginal bleeding during the first trimester, with the majority of episodes occurring between weeks five and eight and resolving on their own. That said, spotting can occasionally point to something that needs medical attention, and telling the difference between harmless bleeding and a warning sign depends on a handful of details your provider will want to evaluate.

How Common First-Trimester Spotting Really Is

The numbers are more reassuring than most people expect. In a large prospective study tracking over 4,500 pregnancies, about a quarter of participants reported at least one bleeding episode during the first trimester, but only 8% of those who bled described it as heavy. The vast majority were spotting or light bleeding, and most episodes lasted fewer than three days. The miscarriage rate among women who experienced bleeding was 12%, compared with 13% among women who had no bleeding at all, a difference that was not statistically meaningful.

A separate analysis reinforced this finding: when researchers looked specifically at spotting or light episodes that were painless and lasted only a day or two, the odds of miscarriage were essentially no higher than baseline risk for women with no bleeding at all. In other words, that faint pink or brown streak on the toilet paper after wiping, if it is not accompanied by cramping and clears up within a couple of days, falls squarely inside the range of normal early-pregnancy experience.

When Spotting Becomes More Concerning

The context around the bleeding matters more than the bleeding itself. What shifts spotting from “probably fine” into “get evaluated soon” is the combination of symptoms and their severity. A population-based cohort study found that the risk of pregnancy loss was markedly higher when vaginal bleeding was accompanied by lower abdominal cramping, with a roughly five-fold increase in the hazard of loss compared with women who had no symptoms. Vaginal bleeding alone, without cramping, still carried an elevated risk in that study, though less dramatically.

Signs that warrant a same-day call to your provider include:

  • Heavy bleeding: soaking a pad within an hour, or passing clots larger than a coin.
  • Cramping on one side: sharp or persistent pain concentrated in the lower pelvis on just one side, which can suggest an ectopic pregnancy.
  • Dizziness or fainting: signs of significant blood loss or internal bleeding.
  • Fever: may indicate infection alongside the bleeding.

Pain that is mild and central, resembling period cramps, is common in early pregnancy because the uterus is stretching. That type of discomfort alongside light spotting is usually not alarming by itself, but mention it at your next appointment so your provider can factor it into the picture.

Subchorionic Hematoma, the Most Common Structural Cause

If your provider orders an early ultrasound and spots a small pocket of blood between the uterine wall and the gestational sac, you will likely hear the term subchorionic hematoma. It is one of the most frequently identified causes of first-trimester spotting, found in roughly 17% of pregnancies in one large cohort. The blood collects when a small portion of the placental edge separates from the uterine lining, and the body usually reabsorbs it over a few weeks.

Size matters here. Small and moderate hematomas carry a miscarriage rate that hovers around 7 to 9%, not dramatically different from the general population rate. Large hematomas, however, have been linked to roughly double that rate and a higher chance of complications like preterm delivery and placental abruption later in pregnancy. A more recent study found similar patterns, with the largest hematomas significantly associated with early pregnancy loss and preterm birth, while smaller ones behaved more like the no-hematoma control group.

An important nuance: in cases where a hematoma was detected on ultrasound but the woman had no bleeding symptoms, pregnancy outcomes were not significantly different from those without a hematoma. It was the symptom of vaginal bleeding itself, rather than the mere presence or size of the hematoma, that appeared to be the better predictor of whether a live birth would follow. So if your ultrasound shows a small hematoma and you have had only minor spotting, the outlook is generally good.

Ruling Out an Ectopic Pregnancy

One of the reasons providers take first-trimester bleeding seriously, even when it is light, is the need to confirm the pregnancy is in the uterus and not in a fallopian tube. Ectopic pregnancies are uncommon but dangerous. Their presentation ranges widely, from no symptoms at all, to pelvic pain that is worse on one side, to a medical emergency involving internal hemorrhage. Transvaginal ultrasound detects about 75% of tubal pregnancies directly.

At six weeks, an intrauterine pregnancy can usually be visualized on transvaginal ultrasound, which is the standard imaging method for evaluating pregnancies in this window. Six weeks is also right around the earliest point at which a fetal heartbeat can be detected using a transvaginal probe; one comparative study placed the earliest transvaginal detection at six weeks and zero days, versus seven weeks for the transabdominal approach. If your provider can see a gestational sac inside the uterus, ectopic pregnancy is essentially off the table. If the ultrasound is inconclusive, which happens more often at the very start of week six because of how small everything is, the next step is usually serial blood tests for hCG.

What hCG Levels and Ultrasound Can Tell You

When an ultrasound at six weeks does not yet show a clear gestational sac or heartbeat, your provider will likely order two blood draws about 48 hours apart to track the pregnancy hormone hCG. In a viable intrauterine pregnancy, hCG rises by at least 53% over two days, though the actual rate varies widely among healthy pregnancies. Earlier guidelines used a 66% threshold, but research showed that the slowest normal rise is actually slower than that, which means a modestly slow rise does not automatically spell trouble.

At the extremes, the numbers are more informative. A study of pregnancies of uncertain viability found that when the hCG level rose by less than 11% over 48 hours, the result was early pregnancy loss in every case. At the other end, a rise of more than 75% was associated with a viable pregnancy every time. The in-between zone, roughly an 11 to 75% rise, is where things are genuinely ambiguous and where a repeat ultrasound a week or so later often provides the clearest answer.

Once a heartbeat is confirmed, its rate offers additional reassurance. An embryonic heart rate above about 113 beats per minute, combined with appropriately sized measurements of the embryo and gestational sac, predicted ongoing viability with a positive predictive value above 97% in one prospective study of women with threatened miscarriage.

Everyday Causes That Have Nothing to Do With the Pregnancy Itself

Not all spotting at six weeks originates from the pregnancy. The cervix becomes engorged with extra blood supply early in pregnancy, making its surface far more sensitive. Sexual intercourse, a vaginal exam, even a bumpy car ride can irritate the cervix enough to produce a streak of blood on the toilet paper. This cervical bleeding is harmless and tends to be brownish or pink, brief, and painless.

Cervical and vaginal infections can also trigger spotting. A study of women with first-trimester bleeding found that 60% had at least one reproductive-tract infection at the time of evaluation. Bacterial vaginosis, trichomoniasis, and chlamydia were each independently associated with first-trimester bleeding. These infections are treatable during pregnancy, and treating them may reduce the risk of preterm birth, so flagging any unusual discharge or odor alongside spotting is worthwhile.

Medications That Can Increase Spotting

If you are taking low-dose aspirin, whether prescribed for a history of preeclampsia or recurrent pregnancy loss, it may be contributing to the spotting. In a randomized trial of preconception low-dose aspirin in women with prior losses, vaginal bleeding was reported by 22% of the aspirin group compared with 17% of those on placebo. A separate analysis found that subchorionic hematomas were almost four times more frequent among women taking low-dose aspirin in the first trimester, regardless of fertility treatment status. This does not mean you should stop aspirin on your own. When it is prescribed for a medical reason, the benefit usually outweighs the risk of some extra spotting. But it does help explain where the bleeding is coming from, and your provider can weigh the trade-off with you.

Blood thinners like heparin, used in some high-risk pregnancies, are another medication class that can increase spotting. If you are on any anticoagulant, your care team should already be monitoring for bleeding, but mention any new spotting promptly.

Thyroid Conditions and Early Pregnancy Bleeding

Both an overactive and an underactive thyroid have been linked to a modestly higher likelihood of early pregnancy bleeding. A large dataset analysis found that hyperthyroidism and hypothyroidism, whether diagnosed before or during pregnancy, each carried a roughly 10 to 11% increase in the odds of bleeding in the first trimester. The effect size is small, but if you have a known thyroid condition, it is one more reason to have your levels checked early in pregnancy. Uncontrolled thyroid disease can also affect pregnancy outcomes independently, so optimizing treatment benefits both you and the pregnancy.

Does Progesterone Help?

You may see progesterone supplements mentioned online as a treatment for early pregnancy bleeding. The largest trial to date, involving over 4,000 women with first-trimester bleeding, found that vaginal progesterone did not produce a statistically significant improvement in live birth rates overall: 75% in the progesterone group versus 72% on placebo.

The picture changes for a specific group. Among women who had experienced three or more prior miscarriages and were bleeding again, progesterone raised the live birth rate from 57% to 72%, a meaningful difference that was statistically significant. For women without that history of recurrent loss, the evidence does not support routine progesterone for first-trimester spotting. If your provider prescribes it, it is most likely because of your specific history rather than the bleeding alone.

Rh Factor and the RhoGAM Question

If your blood type is Rh-negative, you may wonder whether spotting at six weeks requires a RhoGAM (Rh immunoglobulin) injection. Traditionally, Rh-negative women were given RhoGAM for any pregnancy bleeding to prevent sensitization, a condition where the mother’s immune system develops antibodies against the baby’s blood cells. But recent evidence has called this practice into question for very early pregnancy. The amount of fetal blood that crosses into the maternal circulation before 12 weeks appears to be below the threshold needed to trigger sensitization.

A review of the evidence concluded that administering RhoGAM for first-trimester bleeding is based on expert opinion extrapolated from late-pregnancy data rather than direct evidence of benefit. Practice is shifting, but not uniformly. Some providers still give it out of caution. Others follow newer guidance suggesting it can be safely omitted before 12 weeks. If you are Rh-negative and spot at six weeks, ask your provider about their current protocol; the answer may depend on your institution’s policies.

The Emotional Weight of Waiting

The hardest part of first-trimester spotting is often the uncertainty. Research on the emotional experiences of women evaluated in early pregnancy units found that diagnostic uncertainty, waiting days for a follow-up scan or a second hCG draw, was a more powerful driver of anxiety than even receiving bad news. Women whose initial scan was inconclusive, a common outcome at six weeks, experienced sustained anxiety that persisted regardless of whether the pregnancy ultimately turned out to be viable.

A qualitative study documented distinct emotional patterns among women going through early-pregnancy evaluation, ranging from anxious presentation to sustained anxiety during the waiting period, with the experience shaped by how quickly a clear answer was reached and whether additional procedures were needed. If you find yourself in the waiting zone, know that the anxiety is a well-documented response to an inherently uncertain situation, not a sign that something is wrong. Having a plan for how to spend the waiting days, whether that is staying busy, leaning on someone you trust, or limiting how often you search for symptoms online, can make the interval more bearable.

Fibroids and Other Structural Factors

Uterine fibroids, which are benign muscular growths in the uterine wall, affect a significant minority of women of reproductive age. During pregnancy, fibroids can cause bleeding, particularly if they are located near the site where the embryo implanted. Most fibroids do not cause problems in pregnancy, but large ones or those in certain locations can also be associated with pain as they change in response to rising hormone levels. If you already knew about fibroids before getting pregnant, tell your provider about any spotting so they can factor the fibroid’s position and size into the evaluation.

A cervical polyp is another structural finding that sometimes explains unexplained spotting. These small, benign growths on the cervix bleed easily when touched, and the increased blood flow of pregnancy makes them even more friable. They are usually visible during a speculum exam and are rarely a cause for concern.

What Your Provider Visit Will Look Like

If you call your OB or midwife about spotting at six weeks, expect a combination of questions and, depending on your answers, one or more of the following steps. The provider will ask about the color of the blood (bright red, pink, brown), the amount (a few drops when wiping versus filling a liner), whether there is cramping or pain on one side, and how long it has lasted. Brown blood is older and generally less concerning; bright red blood in larger amounts prompts a faster workup.

A transvaginal ultrasound is the first-line tool for evaluation. At six weeks, it can confirm an intrauterine pregnancy, check for a heartbeat (though it may still be too early to see one), and look for a subchorionic hematoma or signs of ectopic pregnancy. If the ultrasound is inconclusive, a blood draw for hCG followed by a repeat draw 48 hours later can clarify the trajectory. A progesterone level may be drawn at the same time, since very low progesterone can be another signal of a non-viable pregnancy, though it is less useful once viability has already been established by ultrasound.

In many cases, you will be told the pregnancy looks fine and to return for your regularly scheduled first prenatal visit or an early dating scan. In some cases, you will be asked to come back in a week for a repeat ultrasound. Try to treat the follow-up appointment as good practice rather than a sign of trouble; the timing of early pregnancy development means that a week can make the difference between an ambiguous scan and a clear heartbeat.